AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Apeloa Pharmaceutical Co.,Ltd

¥22.37 +$6.06 (+37.16%)
SHZ · 15 Sep 2026 07:04 UTC
Previous Close
¥22.68
Day Range
¥21.95¥22.63
Year Range
¥14.89¥24.85
Market Cap
25.91B
AVG Volume
19.15M
Trailing/Forward PE
29.83/20.29
PEG ratio
1.59
Dividend Yield
2.62%
Next Earnings Date
2026-10-16
Primary Exchange
Shenzhen Stock ExchangeCN
Revenue (CNY)
05B10B15B2016201720182019202020212022202320242025
000739.SZ Revenue (CNY) by year
PeriodRevenue (CNY)
20259.78B
202412.02B
202311.47B
202210.54B
20218.94B
20207.88B
20197.21B
20186.38B
20175.55B
20164.77B
Net Income (CNY)
0500M1B1.5B2016201720182019202020212022202320242025
000739.SZ Net Income (CNY) by year
PeriodNet Income (CNY)
2025890.68M
20241.03B
20231.06B
2022989.17M
2021955.55M
2020816.73M
2019553.4M
2018370.56M
2017256.59M
2016262.9M
Operating Income (CNY)
0500M1B1.5B2016201720182019202020212022202320242025
000739.SZ Operating Income (CNY) by year
PeriodOperating Income (CNY)
2025951.01M
20241.21B
20231.22B
20221.01B
20211.35B
2020969.71M
2019644.15M
2018490.53M
2017335.69M
2016366.39M
EBITDA (CNY)
0500M1B1.5B2B2016201720182019202020212022202320242025
000739.SZ EBITDA (CNY) by year
PeriodEBITDA (CNY)
20251.65B
20241.6B
20231.55B
20221.28B
20211.31B
20201.17B
2019935.65M
2018747.16M
2017680.34M
2016565.2M
Cash Flows (CNY)
-500M0500M1B1.5B2016201720182019202020212022202320242025
000739.SZ Cash Flows (CNY) by year
PeriodCash Flows (CNY)
2025833.99M
2024748.01M
2023417.26M
2022494.9M
2021-90.18M
2020742.41M
20191.22B
2018695.75M
20178.75M
2016-150.93M
EPS (CNY)
00.250.50.7512016201720182019202020212022202320242025
000739.SZ EPS (CNY) by year
PeriodEPS (CNY)
20250.77
20240.89
20230.89
20220.84
20210.81
20200.69
20190.47
20180.31
20170.23
20160.23
Expenses (CNY)
01B2B3BR&DSG&ACapex2016201720182019202020212022202320242025
000739.SZ Expenses (CNY) by year
PeriodExpenses (CNY)
20251.9B
20242.22B
20232.38B
20222.02B
20212.04B
20201.62B
20191.79B
20181.67B
20171.56B
20161.59B
Cash & Debt (CNY)
01B2B3B4BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
000739.SZ Cash & Debt (CNY) by year
PeriodCash & Debt (CNY)
20253.79B
20243.66B
20233.58B
20223.55B
20212.62B
20202.31B
20191.5B
2018745.78M
2017551.16M
2016553.01M
Debt ratios
-0.6-0.4-0.2-020182019202020212022202320242025
000739.SZ Debt ratios by year
PeriodDebt ratios
2025-0.37
2024-0.48
2023-0.52
2022-0.58
2021-0.52
2020-0.56
2019-0.47
2018-0.02
Margins
0%10%20%30%40%2016201720182019202020212022202320242025
000739.SZ Margins by year
PeriodMargins
202525.58%
202423.26%
202324.86%
202223.42%
202126.43%
202027.66%
201931.9%
201831.44%
201730.35%
201627.34%
Return on Capital
0%5%10%15%20%2016201720182019202020212022202320242025
000739.SZ Return on Capital by year
PeriodReturn on Capital
202514.03%
202415.28%
202316.94%
202217.92%
202118.88%
202018.6%
201914.69%
201811.08%
20178.41%
201610.05%
Shares Outstanding
0500M1B1.5B2016201720182019202020212022202320242025
000739.SZ Shares Outstanding by year
PeriodShares Outstanding
20251.15B
20241.16B
20231.17B
20221.17B
20211.18B
20201.18B
20191.16B
20181.24B
20171.1B
20161.12B
Dividends (CNY)
00.20.40.60.82017201820192020202120222023202420252026
000739.SZ Dividends (CNY) by year
PeriodDividends (CNY)
20260.24
20250.7
20240.32
20230.3
20220.28
20210.24
20200.17
20190.11
20180.07
20170.07
Book Value Per Share (CNY)
02462016201720182019202020212022202320242025
000739.SZ Book Value Per Share (CNY) by year
PeriodBook Value Per Share (CNY)
20255.53
20245.8
20235.33
20224.71
20214.29
20203.73
20193.25
20182.69
20172.76
20162.33
Total Assets (CNY)
05B10B15B2016201720182019202020212022202320242025
000739.SZ Total Assets (CNY) by year
PeriodTotal Assets (CNY)
202512.32B
202412.73B
202312.77B
202212.02B
20219.04B
20207.49B
20196.52B
20185.75B
20175.69B
20165.62B
PE Ratio
15202530med 18.56Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ PE Ratio by year
PeriodPE Ratio
Sep 2628.65
Sep 2627.72
Sep 2628.24
Aug 2626.95
Aug 2626.18
Aug 2628.49
Aug 2629.58
Jul 2625.55
Jul 2624.86
Jul 2624.83
Jul 2622.74
Jul 2623.05
Jun 2620.55
Jun 2621.08
Jun 2620.7
Jun 2620.77
May 2621.39
May 2621.78
May 2621.38
May 2622.56
Apr 2623.53
Apr 2623.63
Apr 2622.9
Apr 2622.95
Apr 2622.67
Mar 2623.39
Mar 2622.02
Mar 2623.99
Mar 2623.58
Feb 2624.08
Feb 2624.21
Feb 2625.04
Jan 2624.47
Jan 2624.65
Jan 2623.51
Jan 2621.82
Dec 2521.68
Dec 2519.6
Dec 2520.07
Dec 2519.32
Dec 2519.25
Nov 2519.12
Nov 2518.93
Nov 2518.79
Nov 2518.2
Oct 2518.57
Oct 2518.33
Oct 2519.03
Oct 2519.25
Sep 2519.57
Sep 2518.59
Sep 2518.61
Sep 2518.25
Sep 2518.1
Aug 2517.94
Aug 2518.55
Aug 2518.45
Aug 2517.71
Aug 2518.04
Jul 2518.11
Jul 2517.15
Jul 2516.75
Jul 2516.3
Jun 2515.85
Jun 2515.68
Jun 2516.39
Jun 2516.03
May 2515.79
May 2515.62
May 2515.84
May 2515.67
Apr 2515.48
Apr 2515.41
Apr 2515.31
Apr 2515.56
Apr 2517.36
Mar 2516.44
Mar 2516.26
Mar 2516.49
Mar 2518.42
Feb 2518.26
Feb 2516.88
Feb 2516.39
Feb 2516.53
Jan 2516.35
Jan 2516.24
Jan 2516.38
Jan 2516.21
Jan 2516.99
Dec 2417.11
Dec 2417.12
Dec 2417.47
Dec 2417.66
Nov 2417.85
Nov 2416.88
Nov 2417.53
Nov 2418.03
Nov 2417.29
Oct 2417.7
Oct 2417.21
Free Cash Flow Yield
1%2%3%4%5%med 3.81%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 263.88%
Sep 264.01%
Sep 263.94%
Aug 264.12%
Aug 264.25%
Aug 263.9%
Aug 263.76%
Jul 264.35%
Jul 264.47%
Jul 264.48%
Jul 264.89%
Jul 264.82%
Jun 264.56%
Jun 264.44%
Jun 264.52%
Jun 264.51%
May 264.38%
May 264.3%
May 264.38%
May 264.15%
Apr 263.98%
Apr 263.96%
Apr 264.09%
Apr 264.08%
Apr 264.13%
Mar 262.52%
Mar 262.68%
Mar 262.46%
Mar 262.5%
Feb 262.45%
Feb 262.43%
Feb 262.35%
Jan 262.41%
Jan 262.39%
Jan 262.51%
Jan 262.7%
Dec 252.72%
Dec 251.23%
Dec 251.2%
Dec 251.25%
Dec 251.25%
Nov 251.26%
Nov 251.28%
Nov 251.29%
Nov 251.33%
Oct 251.3%
Oct 251.32%
Oct 251.27%
Oct 251.25%
Sep 251.23%
Sep 252.71%
Sep 252.71%
Sep 252.76%
Sep 252.79%
Aug 252.81%
Aug 252.72%
Aug 252.73%
Aug 252.85%
Aug 252.8%
Jul 252.78%
Jul 252.94%
Jul 253.01%
Jul 253.1%
Jun 254.58%
Jun 254.63%
Jun 254.43%
Jun 254.53%
May 254.59%
May 254.64%
May 254.58%
May 254.63%
Apr 254.69%
Apr 254.71%
Apr 254.74%
Apr 254.66%
Apr 254.18%
Mar 254.33%
Mar 254.38%
Mar 254.32%
Mar 253.86%
Feb 253.9%
Feb 254.22%
Feb 254.34%
Feb 254.31%
Jan 254.35%
Jan 254.38%
Jan 254.35%
Jan 254.39%
Jan 254.19%
Dec 243.44%
Dec 243.44%
Dec 243.37%
Dec 243.34%
Nov 243.3%
Nov 243.49%
Nov 243.36%
Nov 243.27%
Nov 243.41%
Oct 243.33%
Oct 243.43%
Price to Sales
11.522.53med 1.65Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ Price to Sales by year
PeriodPrice to Sales
Sep 262.69
Sep 262.6
Sep 262.65
Aug 262.53
Aug 262.46
Aug 262.67
Aug 262.77
Jul 262.4
Jul 262.33
Jul 262.33
Jul 262.13
Jul 262.16
Jun 261.87
Jun 261.92
Jun 261.88
Jun 261.89
May 261.95
May 261.98
May 261.95
May 262.05
Apr 262.14
Apr 262.15
Apr 262.08
Apr 262.09
Apr 262.06
Mar 261.92
Mar 261.81
Mar 261.97
Mar 261.94
Feb 261.98
Feb 261.99
Feb 262.06
Jan 262.01
Jan 262.02
Jan 261.93
Jan 261.79
Dec 251.78
Dec 251.72
Dec 251.76
Dec 251.7
Dec 251.69
Nov 251.68
Nov 251.66
Nov 251.65
Nov 251.6
Oct 251.63
Oct 251.61
Oct 251.67
Oct 251.69
Sep 251.72
Sep 251.67
Sep 251.67
Sep 251.64
Sep 251.62
Aug 251.61
Aug 251.66
Aug 251.65
Aug 251.59
Aug 251.62
Jul 251.62
Jul 251.54
Jul 251.5
Jul 251.46
Jun 251.36
Jun 251.35
Jun 251.41
Jun 251.37
May 251.35
May 251.34
May 251.36
May 251.34
Apr 251.33
Apr 251.32
Apr 251.31
Apr 251.33
Apr 251.49
Mar 251.44
Mar 251.42
Mar 251.44
Mar 251.61
Feb 251.6
Feb 251.48
Feb 251.43
Feb 251.45
Jan 251.43
Jan 251.42
Jan 251.43
Jan 251.42
Jan 251.49
Dec 241.55
Dec 241.55
Dec 241.58
Dec 241.59
Nov 241.61
Nov 241.52
Nov 241.58
Nov 241.63
Nov 241.56
Oct 241.6
Oct 241.55
EV/EBITDA
7.51012.51517.5med 10.34Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ EV/EBITDA by year
PeriodEV/EBITDA
Sep 2616.07
Sep 2615.53
Sep 2615.83
Aug 2615.09
Aug 2614.65
Aug 2615.98
Aug 2616.6
Jul 2614.28
Jul 2613.89
Jul 2613.87
Jul 2612.67
Jul 2612.84
Jun 269.71
Jun 2610
Jun 269.79
Jun 269.83
May 2610.16
May 2610.37
May 2610.16
May 2610.8
Apr 2611.32
Apr 2611.37
Apr 2610.98
Apr 2611
Apr 2610.85
Mar 2614.81
Mar 2613.92
Mar 2615.2
Mar 2614.94
Feb 2615.27
Feb 2615.35
Feb 2615.89
Jan 2615.52
Jan 2615.64
Jan 2614.89
Jan 2613.79
Dec 2513.7
Dec 2511.06
Dec 2511.37
Dec 2510.89
Dec 2510.84
Nov 2510.75
Nov 2510.63
Nov 2510.55
Nov 2510.16
Oct 2510.4
Oct 2510.25
Oct 2510.7
Oct 2510.84
Sep 2511.05
Sep 2510.74
Sep 2510.76
Sep 2510.52
Sep 2510.42
Aug 2510.31
Aug 2510.72
Aug 2510.65
Aug 2510.15
Aug 2510.38
Jul 2510.43
Jul 259.78
Jul 259.51
Jul 259.2
Jun 258.48
Jun 258.37
Jun 258.83
Jun 258.6
May 258.45
May 258.34
May 258.47
May 258.37
Apr 258.24
Apr 258.2
Apr 258.13
Apr 258.29
Apr 259.46
Mar 258.54
Mar 258.42
Mar 258.56
Mar 259.77
Feb 259.67
Feb 258.81
Feb 258.5
Feb 258.59
Jan 258.48
Jan 258.41
Jan 258.5
Jan 258.39
Jan 258.88
Dec 249.46
Dec 249.46
Dec 249.7
Dec 249.82
Nov 249.95
Nov 249.31
Nov 249.73
Nov 2410.07
Nov 249.58
Oct 249.85
Oct 249.52
Price/Operating Cashflow
101520253035med 16.63Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2618.77
Sep 2618.16
Sep 2618.5
Aug 2617.66
Aug 2617.15
Aug 2618.67
Aug 2619.38
Jul 2616.74
Jul 2616.29
Jul 2616.27
Jul 2614.9
Jul 2615.1
Jun 2615
Jun 2615.39
Jun 2615.11
Jun 2615.16
May 2615.61
May 2615.9
May 2615.6
May 2616.47
Apr 2617.17
Apr 2617.25
Apr 2616.71
Apr 2616.75
Apr 2616.55
Mar 2624.67
Mar 2623.22
Mar 2625.3
Mar 2624.86
Feb 2625.4
Feb 2625.54
Feb 2626.41
Jan 2625.81
Jan 2626
Jan 2624.79
Jan 2623.01
Dec 2522.87
Dec 2529.9
Dec 2530.63
Dec 2529.49
Dec 2529.38
Nov 2529.18
Nov 2528.88
Nov 2528.68
Nov 2527.77
Oct 2528.34
Oct 2527.97
Oct 2529.05
Oct 2529.38
Sep 2529.87
Sep 2521.07
Sep 2521.1
Sep 2520.69
Sep 2520.52
Aug 2520.35
Aug 2521.04
Aug 2520.92
Aug 2520.08
Aug 2520.46
Jul 2520.54
Jul 2519.45
Jul 2518.99
Jul 2518.48
Jun 2513.52
Jun 2513.38
Jun 2513.98
Jun 2513.68
May 2513.47
May 2513.33
May 2513.51
May 2513.37
Apr 2513.2
Apr 2513.15
Apr 2513.06
Apr 2513.27
Apr 2514.81
Mar 2513.09
Mar 2512.95
Mar 2513.13
Mar 2514.66
Feb 2514.53
Feb 2513.44
Feb 2513.05
Feb 2513.16
Jan 2513.01
Jan 2512.93
Jan 2513.04
Jan 2512.9
Jan 2513.53
Dec 2414.54
Dec 2414.55
Dec 2414.85
Dec 2415.01
Nov 2415.17
Nov 2414.35
Nov 2414.9
Nov 2415.33
Nov 2414.7
Oct 2415.04
Oct 2414.62
Price to Book
22.533.544.5med 2.88Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
000739.SZ Price to Book by year
PeriodPrice to Book
Sep 263.89
Sep 263.76
Sep 263.83
Aug 263.66
Aug 263.55
Aug 263.86
Aug 264.01
Jul 263.47
Jul 263.37
Jul 263.37
Jul 263.09
Jul 263.13
Jun 262.88
Jun 262.96
Jun 262.9
Jun 262.92
May 263
May 263.06
May 263
May 263.17
Apr 263.3
Apr 263.32
Apr 263.21
Apr 263.22
Apr 263.18
Mar 263.1
Mar 262.92
Mar 263.18
Mar 263.13
Feb 263.2
Feb 263.21
Feb 263.32
Jan 263.25
Jan 263.27
Jan 263.12
Jan 262.89
Dec 252.88
Dec 252.81
Dec 252.88
Dec 252.77
Dec 252.76
Nov 252.74
Nov 252.72
Nov 252.7
Nov 252.61
Oct 252.66
Oct 252.63
Oct 252.73
Oct 252.76
Sep 252.81
Sep 252.75
Sep 252.75
Sep 252.7
Sep 252.68
Aug 252.66
Aug 252.75
Aug 252.73
Aug 252.62
Aug 252.67
Jul 252.68
Jul 252.54
Jul 252.48
Jul 252.41
Jun 252.42
Jun 252.4
Jun 252.5
Jun 252.45
May 252.41
May 252.39
May 252.42
May 252.39
Apr 252.36
Apr 252.35
Apr 252.34
Apr 252.38
Apr 252.65
Mar 252.68
Mar 252.65
Mar 252.69
Mar 253
Feb 252.98
Feb 252.75
Feb 252.67
Feb 252.69
Jan 252.66
Jan 252.65
Jan 252.67
Jan 252.64
Jan 252.77
Dec 242.91
Dec 242.91
Dec 242.97
Dec 243
Nov 243.04
Nov 242.87
Nov 242.98
Nov 243.07
Nov 242.94
Oct 243.01
Oct 242.93
Apeloa Pharmaceutical Co.,Ltd
000739.SZ
Stockpicker

Video analysis: 000739.SZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.